Clean Your Email List with Our Free Verifier Tool! ➡️ Verify Emails Now🚀
We are Angelini Pharma Switzerland, the pharmaceutical division of Angelini Industries and formerly Arvelle Therapeutics International GmbH. The company started more than100 years ago as a local pharmaceutical laboratory. Angelini Pharma is the pharmaceutical division of Angelini Industries that has grown through the years into a leading international company present in pharmaceuticals and the mass-market. Angelini Pharma is a leader in healthcare with particular expertise in Brain Health focusing in the fields of Mental Health and Epilepsy. The company is also a leading player in the Consumer Health segment with highly successful OTC brands marketed worldwide. Angelini Pharma operates directly in 20 countries, employing almost 3,000 people and commercialises its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups. In Switzerland the commercial organization operates with its branch located in Zug, Angelini Pharma Zug S.p.A. and employs approximately 15 people at its headquarters. The dedication of the team is driven by passion to improve the lives of patients who are affected by Epilepsy and diseases that impact Brain Health. Angelini Pharma was awarded and recognized as the best employer in Europe for the third consecutive year for the development and well-being of their employees guaranteeing the best working conditions. The company continues to research, develop, and commercialize health solutions that impact Brain Health. The research embraces public-private partnerships with recognized academic institutions and centers of global importance. The Scientific Network and our Partnerships in Switzerland both have an important role in creating innovation within the topical anti-inflammatory, anti-depressant, and pain management sectors. Contact us to find out more about our company and leadership team located in Zug at info.ch@angelinipharma.com or +41 (0) 417115882 View More
